Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endo International PLC (NASDAQ:ENDP)

13.09
BATS BZX Real-Time Price
As of 3:36pm ET
 +0.02 / +0.15%
Today’s Change
12.56
Today|||52-Week Range
61.14
-20.52%
Year-to-Date
The Worst Performing Stock of 2016
Jan 17 / MotleyFool.com - Paid Partner Content
Implied Volatility Surging for Endo International (ENDP) Stock Options
Jan 04 / Zacks.com - Paid Partner Content
Deja Vu for Drug Stocks as Trump Slams Drug Pricing Again
Jan 12 / Zacks.com - Paid Partner Content
Endo International (ENDP): Can the Stock Rebound in 2017?
Jan 04 / Zacks.com - Paid Partner Content
The 10 Worst Stocks in the S&P 500 in 2016
Jan 08 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close13.07
Today’s open13.20
Day’s range12.68 - 13.25
Volume695,065
Average volume (3 months)5,575,357
Market cap$2.9B
Dividend yield--
Data as of 3:36pm ET, 01/18/2017

Growth & Valuation

Earnings growth (last year)-55.88%
Earnings growth (this year)-1.40%
Earnings growth (next 5 years)+2.00%
Revenue growth (last year)+13.61%
P/E ratio4.5
Price/Sales3.69
Price/Book0.49

Competitors

 Today’s
change
Today’s
% change
RAREUltragenyx Pharmaceu...+0.79+1.14%
CBPOChina Biologic Produ...+3.80+3.65%
ICPTIntercept Pharmaceut...+2.36+2.08%
GWPHGW Pharmaceuticals P...+0.46+0.38%
Data as of 3:36pm ET, 01/18/2017

Financials

Next reporting dateFebruary 28, 2017
EPS forecast (this quarter)$1.65
Annual revenue (last year)$3.3B
Annual profit (last year)-$1.5B
Net profit margin-9.18%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Paul V. Campanelli
Chief Operating Officer &
Executive Vice President
Terrance J. Coughlin
Corporate headquarters
Dublin, Dublin

Forecasts


Search for Jobs